CTCAE Neutropenia Grade

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۵۰۰۰۰ • واحد: /mm³

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
grade
—grade
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Grade 11–1
  • Grade 22–2
  • Grade 33–3
  • Grade 44–4
Direct Clinical Answer

The CTCAE Neutropenia Grade calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include anc. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

CTCAE neutropenia grading from the absolute neutrophil count (ANC): Grade 1 (<LLN-1500), Grade 2 (<1500-1000), Grade 3 (<1000-500), Grade 4 (<500 /mm³). Standard oncology toxicity grading for chemotherapy decisions and growth-factor support.

Clinical Indication

The CTCAE Neutropenia Grade is indicated for bedside clinical practice to support CTCAE neutropenia grading from the absolute neutrophil count (ANC): Grade 1 (<LLN-1500), Grade 2 (<1500-1000), Grade 3 (<1000-500), Grade 4 (<500 /mm³). Standard oncology toxicity grading for chemotherapy decisions and growth-factor support.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.

Formula & Variables:

Grade by ANC thresholds (CTCAE v5)

Input Parameters

NameTypeRequiredDescription
ancfloatYesAbsolute neutrophil count(/mm³)

Score Interpretation & Guidance

RangeStageDescription
1–1Grade 1Grade 1
2–2Grade 2Grade 2
3–3Grade 3Grade 3
4–4Grade 4Grade 4
0–0No neutropeniaNo neutropenia

Evidence-Based References (EBM)

  • National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Neutrophil count decreased.

Related calculators